April L.

April Loui, MBA, CSSBB, is a seasoned professional with extensive experience in quality and regulatory management within the biopharmaceutical industry. Currently serving as an Advisory Board Member for the US Pharmacopeia and as Senior Vice President of Quality and CMC Regulatory at ReCode Therapeutics, April also holds the position of Founder and CEO at Clarity Global, LLC. Previous roles include Vice President of Quality at Alector and Senior Director of Clinical Quality at Gilead Sciences. April has contributed to several advisory boards, including those at San Francisco State University and Rutgers University. April's educational background includes an Executive Program in Women in Leadership from Yale School of Management, a Healthcare Compliance certification from Seton Hall University School of Law, and an MBA from Saint Mary's College of California, among other qualifications.